Marcus Borenäs

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Advanced Non Small Cell Lung Cancer

Oxidative Stress

Magnetic Resonance

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)
Marcus Borenäs, Ganesh Umapathy, Dan Emil Lind, Wei-Yun Lai, Jikui Guan, Joel Johansson, Eva Jennische, Alexander Schmidt, Yeshwant Kurhe, Jonatan L Gabre, Agata Aniszewska, Anneli Strömberg, Mats Bemark, Michael N Hall, Jimmy Van den Eynden, Bengt Hallberg, Ruth H Palmer
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition. Proceedings of the National Academy of Sciences of the United States of America 121 (1) (2023)